{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T22:58:07Z","timestamp":1782860287880,"version":"3.54.5"},"reference-count":95,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T00:00:00Z","timestamp":1782777600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T00:00:00Z","timestamp":1782777600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s11033-026-12187-x","type":"journal-article","created":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T22:14:06Z","timestamp":1782857646000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Berberine in breast cancer, a multi-targeted therapeutic agent from mechanisms to clinical translation"],"prefix":"10.1007","volume":"53","author":[{"given":"Haokun","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Nian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,30]]},"reference":[{"key":"12187_CR1","doi-asserted-by":"publisher","first-page":"130598","DOI":"10.1016\/j.bmcl.2026.130598","volume":"136","author":"YH Liao","year":"2026","unstructured":"Liao YH, Wang YJ, Wang JQ et al (2026) Discovery of C-9 boronated berberine derivatives with enhanced selectivity against breast cancer. Bioorg Med Chem Lett136:130598. https:\/\/doi.org\/10.1016\/j.bmcl.2026.130598","journal-title":"BIOORG MED CHEM LETT"},{"issue":"1","key":"12187_CR2","doi-asserted-by":"publisher","first-page":"49","DOI":"10.3760\/cma.j.issn.1673-422X.2017.01.013","volume":"44","author":"T Li Wenbin","year":"2017","unstructured":"Li Wenbin T, Han Z, Jieya et al (2017) Safety of nipple-areola complex-sparing modified radical mastectomy for breast cancer [J]. J Int Oncol 44(1):49\u201352. 10.3760 \/cma.j.issn.1673-422X.2017.01.013","journal-title":"J Int Oncol"},{"issue":"9","key":"12187_CR3","doi-asserted-by":"publisher","first-page":"3233","DOI":"10.3390\/ijms21093233","volume":"21","author":"K Bukowski","year":"2020","unstructured":"Bukowski K, Kciuk M, Kontek R (2020) Mechanisms of multidrug resistance in cancer chemotherapy [J]. Int J Mol Sci 21(9):3233","journal-title":"Int J Mol Sci"},{"issue":"4","key":"12187_CR4","doi-asserted-by":"publisher","first-page":"549","DOI":"10.26444\/aaem\/75943","volume":"24","author":"A Kolak","year":"2017","unstructured":"Kolak A, Kami\u0144ska M, Sygit K et al (2017) Primary and secondary prevention of breast cancer [J]. Ann Agric Environ Med 24(4):549\u2013553","journal-title":"Ann Agric Environ Med"},{"issue":"05","key":"12187_CR5","first-page":"545","volume":"39","author":"R Shi Mengjie","year":"2021","unstructured":"Shi Mengjie R, Zhangpeng Z, Zijing et al (2021) Effects of berberine combined with tamoxifen on the biological behavior of drug-resistant breast cancer T-47D cells [J]. J Guangdong Med Univ 39(05):545\u2013549","journal-title":"J Guangdong Med Univ"},{"key":"12187_CR6","doi-asserted-by":"publisher","first-page":"557","DOI":"10.3389\/fphar.2018.00557","volume":"9","author":"A Neag","year":"2018","unstructured":"Neag A, Mocan A, Echeverr\u00eda J et al (2018) Berberine: Botanical Occurrence, Traditional Uses, Extraction Methods, and Relevance in Cardiovascular, Metabolic, Hepatic, and Renal Disorders. Front Pharmacol 9:557. https:\/\/doi.org\/10.3389\/fphar.2018.00557","journal-title":"Front Pharmacol"},{"key":"12187_CR7","doi-asserted-by":"publisher","first-page":"993775","DOI":"10.3389\/fonc.2022.993775","volume":"12","author":"XD Zhong","year":"2022","unstructured":"Zhong XD, Chen LJ, Xu XY, Liu YJ, Tao F, Zhu MH, Li CY, Zhao D, Yang GJ, Chen J (2022) Berberine as a potential agent for breast cancer therapy. Front Oncol 12:993775. https:\/\/doi.org\/10.3389\/fonc.2022.993775","journal-title":"Front Oncol"},{"key":"12187_CR8","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.3389\/fphar.2019.01461","volume":"10","author":"C Zhang","year":"2020","unstructured":"Zhang C, Sheng J, Li G, Zhao L, Wang Y, Yang W, Yao X, Sun L, Zhang Z, Cui R (2020) Effects of Berberine and its derivatives on cancer: A systems Pharmacology review. Front Pharmacol 10:1461. https:\/\/doi.org\/10.3389\/fphar.2019.01461","journal-title":"Front Pharmacol"},{"issue":"23","key":"12187_CR9","doi-asserted-by":"publisher","first-page":"7368","DOI":"10.3390\/molecules26237368","volume":"26","author":"A Rauf","year":"2021","unstructured":"Rauf A, Abu-Izneid T, Khalil AA, Imran M, Shah ZA, Emra TB, Mitra S, Khan Z, Alhumaydhi FA, Aljohani ASM, Khan I, Rahman MM, Jeandet P, Gondal TA (2021) Berberine as a potential anticancer agent: A comprehensive review. Molecules 26(23):7368. https:\/\/doi.org\/10.3390\/molecules26237368","journal-title":"Molecules"},{"issue":"1","key":"12187_CR10","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1007\/s11033-025-10815-6","volume":"52","author":"S Chakraborty","year":"2025","unstructured":"Chakraborty S, Ghosh BN (2025) Berberine and its impact on breast cancer: unveiling key signalling pathways. Mol Biol Rep 52(1):719. https:\/\/doi.org\/10.1007\/s11033-025-10815-6","journal-title":"Mol Biol Rep"},{"key":"12187_CR11","doi-asserted-by":"publisher","first-page":"107742","DOI":"10.1016\/j.phrs.2025.107742","volume":"216","author":"G Chen","year":"2025","unstructured":"Chen G, Zhang C, Zou J et al (2025) Coptidis rhizoma and berberine as anti-cancer drugs: A 10-year updates and future perspectives. Pharmacol Res 216:107742. https:\/\/doi.org\/10.1016\/j.phrs.2025.107742","journal-title":"Pharmacol Res"},{"key":"12187_CR12","doi-asserted-by":"publisher","first-page":"153440","DOI":"10.1016\/j.bbrc.2026.153440","volume-title":"Berberine induces pyroptosis by promoting the NLRP3\/Caspase-1\/GSDMD pathway in papillary thyroid carcinoma","author":"X Huang","year":"2026","unstructured":"Huang X, Lu Y, Li S et al (2026) Berberine induces pyroptosis by promoting the NLRP3\/Caspase-1\/GSDMD pathway in papillary thyroid carcinoma, vol 809. Biochem Bioph Res Co., p 153440. https:\/\/doi.org\/10.1016\/j.bbrc.2026.153440"},{"key":"12187_CR13","doi-asserted-by":"publisher","unstructured":"Liu Mengmeng (2022) Therapeutic Effect of Berberine on Pancreatic Cancer and Its Mechanism [D]. Dalian University of Technology. https:\/\/doi.org\/10.26991\/d.cnki.gdllu.2022.000177","DOI":"10.26991\/d.cnki.gdllu.2022.000177"},{"issue":"1\u20133","key":"12187_CR14","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.ejphar.2010.07.037","volume":"645","author":"JB Patil","year":"2010","unstructured":"Patil JB, Kim J, Jayaprakasha GK (2010) Berberine induces apoptosis in breast cancer cells (MCF-7) through mitochondrialdependent pathway. Eur J Pharmacol 645(1\u20133):70\u201378. https:\/\/doi.org\/10.1016\/j.ejphar.2010.07.037","journal-title":"Eur J Pharmacol"},{"issue":"11","key":"12187_CR15","first-page":"1966","volume":"32","author":"Z Meng Zhaojie","year":"2016","unstructured":"Meng Zhaojie Z et al (2016) Ming,. Berberine promotes breast cancer cell apoptosis by regulating miRNA-146a . Chin J Pathophysiology 32(11):1966\u20131971","journal-title":"Chin J Pathophysiology"},{"issue":"05","key":"12187_CR16","doi-asserted-by":"publisher","first-page":"407","DOI":"10.16466\/j.issn1005-5509.2019.05.004","volume":"43","author":"H Zhao","year":"2019","unstructured":"Zhao H, Like W, Yuanyuan H et al (2019) Study on berberine promoting triple-negative breast cancer cell apoptosis by inhibiting GRP78 expression [J]. J Zhejiang Chin Med Univ 43(05):407\u2013412. https:\/\/doi.org\/10.16466\/j.issn1005-5509.2019.05.004","journal-title":"J Zhejiang Chin Med Univ"},{"issue":"11","key":"12187_CR17","first-page":"7","volume":"46","author":"Z Guo Xiaodan","year":"2024","unstructured":"Guo Xiaodan Z, Jianhua C (2024) Sensitization Effect and Mechanism of Berberine on Chemotherapy in Human Breast Cancer Drug-Resistant Cell Line MCF-7\/ADR [J]. Hubei J Traditional Chin Med 46(11):7\u201312","journal-title":"Hubei J Traditional Chin Med"},{"issue":"2","key":"12187_CR18","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1042\/BJ20101569","volume":"434","author":"M Ni","year":"2011","unstructured":"Ni M, Zhang Y, Lee AS (2011) Beyond the endoplasmic reticulum: atypical GRP78 in cell viability, signalling and therapeutic targeting [J]. Biochem J 434(2):181\u2013188","journal-title":"Biochem J"},{"issue":"1","key":"12187_CR19","doi-asserted-by":"publisher","first-page":"567","DOI":"10.3892\/or.2016.4785","volume":"36","author":"Y Zhao","year":"2016","unstructured":"Zhao Y, Jing Z, Li Y, Mao W (2016) Berberine in combination with cisplatin suppresses breast cancer cell growth through induction of DNA breaks and caspase-3-dependent apoptosis. Oncol Rep 36(1):567\u2013572. https:\/\/doi.org\/10.3892\/or.2016.4785","journal-title":"Oncol Rep"},{"issue":"02","key":"12187_CR20","first-page":"211","volume":"31","author":"X Chen","year":"2024","unstructured":"Chen X, Li H (2024) Application effect and research progress of berberine in regulating Bcl-2\/Bax signalling pathway to induce apoptosis. Pharm Biotechnol 31(02):211\u2013215","journal-title":"Pharm Biotechnol"},{"issue":"4","key":"12187_CR21","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.31557\/APJCP.2025.26.4.1313","volume":"26","author":"R Mutiah","year":"2025","unstructured":"Mutiah R, Zahiro SR, Nafisah TJ et al (2025) Exploring the Therapeutic Potential of Oxo berberine Compound in Arcangelisia flava Root Extract for Breast Cancer Treatment: Metabolite Profiling, Pharmacological Network Analysis, and In Silico and In Vitro Evaluation. Asian Pac J Cancer Prev 26(4):1313\u20131328. https:\/\/doi.org\/10.31557\/APJCP.2025.26.4.1313","journal-title":"Asian Pac J Cancer Prev"},{"key":"12187_CR22","doi-asserted-by":"publisher","unstructured":"Zhou YA, Molecular Mechanism-Based, Approach (2025) Differences in the Roles of Berberine, Quercetin and Baicalin in the Treatment of Breast Cancer IJPHMR. 4(2):10\u201318. https:\/\/doi.org\/10.62051\/ijphmr.v4n2.02","DOI":"10.62051\/ijphmr.v4n2.02"},{"issue":"1\u20132","key":"12187_CR23","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1007\/s11010-019-03529-4","volume":"458","author":"J Tak","year":"2019","unstructured":"Tak J, Sabarwal A, Shyanti RK, Singh RP (2019) Berberine enhances posttranslational protein stability of p21\/cip1 in breast cancer cells via down-regulation of Akt. Mol Cell Biochem 458(1\u20132):49\u201345. https:\/\/doi.org\/10.1007\/s11010-019-03529-4","journal-title":"Mol Cell Biochem"},{"key":"12187_CR24","doi-asserted-by":"publisher","first-page":"152473","DOI":"10.1016\/j.bbrc.2025.152473","volume":"781","author":"Z Demirci","year":"2025","unstructured":"Demirci Z, Yesilay G, Nalbantoglu B et al (2025) Combination of Berberine and NVP-BEZ235 inhibits metastasis of triple-negative breast cancer MDA-MB-231 cell line. Biochem Biophys Res Commun 781:152473. https:\/\/doi.org\/10.1016\/j.bbrc.2025.152473","journal-title":"Biochem Biophys Res Commun"},{"issue":"7","key":"12187_CR25","doi-asserted-by":"publisher","first-page":"e70375","DOI":"10.1002\/jbt.70375","volume":"39","author":"NE El-Ashmawy","year":"2025","unstructured":"El-Ashmawy NE, Khedr EG, El-Adawy SA et al (2025) Berberine-Induced Cytotoxicity in Breast Cancer Is Mediated by Reversal of EMT and Repression of Sirtuin 1\/AKT Signaling Pathways. J Biochem Mol Toxicol 39(7):e70375. https:\/\/doi.org\/10.1002\/jbt.70375","journal-title":"J Biochem Mol Toxicol"},{"issue":"2","key":"12187_CR26","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1159\/000487171","volume":"45","author":"S Kim","year":"2018","unstructured":"Kim S, Lee J, You D, Jeong Y, Jeon M, Yu J, Kim SW, Nam SJ, Lee JE (2018) Berberine suppresses cell motility through downregulation of TGF-\u03b21 in triple negative breast Cancer cells. Cell Physiol Biochem 45(2):795\u2013807. https:\/\/doi.org\/10.1159\/000487171","journal-title":"Cell Physiol Biochem"},{"issue":"1","key":"12187_CR27","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1111\/cas.15609","volume":"114","author":"Y Yamamoto","year":"2023","unstructured":"Yamamoto Y, Kasashima H, Fukui Y, Tsujio G, Yashiro M, Maeda K (2023) The heterogeneity of cancer-associated fibroblast subpopulations: Their origins, biomarkers, and roles in the tumor microenvironment. Cancer Sci 114(1):16\u201324","journal-title":"Cancer Sci"},{"key":"12187_CR28","doi-asserted-by":"publisher","DOI":"10.27740\/d.cnki.gqhdx.2023.000900","author":"Y Zhao","year":"2023","unstructured":"Zhao Y (2023) Network-based pharmacological study on the effect of Tongjiao and Xuebao Tang on breast cancer cells and its mechanism. Qinghai Univ. https:\/\/doi.org\/10.27740\/d.cnki.gqhdx.2023.000900","journal-title":"Qinghai Univ"},{"key":"12187_CR29","doi-asserted-by":"publisher","unstructured":"Zhang M (2021) Doxorubicin induces migration and invasion of breast cancer cells via VWF and the interventive effect of berberine [D]. Jilin University. https:\/\/doi.org\/10.27162\/d.cnki.gjlin.2021.003117","DOI":"10.27162\/d.cnki.gjlin.2021.003117"},{"key":"12187_CR30","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1002\/ijc.2910610205","volume":"61","author":"F Penault-Llorca","year":"1995","unstructured":"Penault-Llorca F, Bertucci F, Ad\u00e9la\u00efde J, Parc P, Coulier F, Jacquemier J et al (1995) Expression of FGF and FGF receptor genes in human breast cancer. Int J Cancer 61:170\u2013176","journal-title":"Int J Cancer"},{"issue":"17","key":"12187_CR31","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1111\/1759-7714.15321","volume":"15","author":"W Fu","year":"2024","unstructured":"Fu W, Liu L, Tong S (2024) Berberine inhibits the progression of breast cancer by regulating METTL3-mediated m6A modification of FGF7 mRNA. Thorac Cancer 15(17):1357\u20131368. https:\/\/doi.org\/10.1111\/1759-7714.15321","journal-title":"Thorac Cancer"},{"key":"12187_CR32","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/s12943-021-01447-y","volume":"21","author":"W Wan","year":"2022","unstructured":"Wan W, Ao X, Chen Q, Yu Y, Ao L, Xing W et al (2022) METTL3\/IGF2BP3 axis inhibits tumor immune surveillance by upregulating N(6)- methyladenosine modification of PD-L1 mRNA in breast cancer. Mol Cancer 21:60","journal-title":"Mol Cancer"},{"key":"12187_CR33","doi-asserted-by":"publisher","first-page":"1679","DOI":"10.7150\/jca.19106","volume":"8","author":"Y Pan","year":"2017","unstructured":"Pan Y, Zhang F, Zhao Y, Shao D, Zheng X, Chen Y, He K et al (2017) Berberine enhances chemosensitivity and induces apoptosis through dose-orchestrated AMPK signaling in breast cancer. J Cancer 8:1679\u20131689","journal-title":"J Cancer"},{"key":"12187_CR34","doi-asserted-by":"publisher","first-page":"794","DOI":"10.7150\/ijbs.18969","volume":"13","author":"Y Pan","year":"2017","unstructured":"Pan Y, Shao D, Zhao Y, Zhang F, Zheng X, Tan Y, He K et al (2017) Berberine Reverses Hypoxia-induced Chemoresistance in Breast Cancer through the Inhibition of AMPK- HIF-1\u03b1. Int J Biol Sci 13:794\u2013803","journal-title":"Int J Biol Sci"},{"key":"12187_CR35","doi-asserted-by":"publisher","first-page":"1530","DOI":"10.5114\/AOMS\/132969","volume":"19","author":"Q Li","year":"2023","unstructured":"Li Q, Zhao H, Chen W, Huang P (2023) Berberine induces apoptosis and arrests the cell cycle in multiple cancer cell lines. Arch Med Sci 19:1530\u20131537. https:\/\/doi.org\/10.5114\/AOMS\/132969","journal-title":"Arch Med Sci"},{"key":"12187_CR36","doi-asserted-by":"publisher","unstructured":"Sajeev A, Sailo B, Unnikrishnan J, Talukdar A, Alqahtani MS, Abbas M, Alqahtani A, Sethi G, Kunnumakkara AB (2024) Unlocking the potential of Berberine: advancing cancer therapy through chemosensitization and combination treatments. Cancer Lett 597. https:\/\/doi.org\/10.1016\/j.canlet.2024.217019 CANLET.2024.217019.","DOI":"10.1016\/j.canlet.2024.217019"},{"key":"12187_CR37","doi-asserted-by":"publisher","first-page":"102984","DOI":"10.1016\/J.JDDST.2021.102984","volume":"67","author":"S Mozaffari","year":"2022","unstructured":"Mozaffari S, Seyedabadi S, Alemzadeh E (2022) Anticancer efficiency of doxorubicin and berberine-loaded PCL nanofibers in preventing local breast cancer recurrence. J Drug Deliv Sci Technol 67:102984. https:\/\/doi.org\/10.1016\/J.JDDST.2021.102984","journal-title":"J Drug Deliv Sci Technol"},{"issue":"Pt 4","key":"12187_CR38","doi-asserted-by":"publisher","first-page":"136484","DOI":"10.1016\/j.ijbiomac.2024.136484","volume":"281","author":"J Wu","year":"2024","unstructured":"Wu J, Li Y, Sun S et al (2024) The pH-sensitive chondroitin sulphate-based nanoparticles for co-delivery of doxorubicin and berberine enhance the treatment of breast cancer. INT J BIOL MACROMOL 281(Pt 4):136484. https:\/\/doi.org\/10.1016\/j.ijbiomac.2024.136484","journal-title":"INT J BIOL MACROMOL"},{"key":"12187_CR39","doi-asserted-by":"publisher","first-page":"125134","DOI":"10.1016\/j.ijpharm.2024.125134","volume":"670","author":"Y Shi","year":"2025","unstructured":"Shi Y, Cao L, Zhao W et al (2025) Enhancing chemo-immunotherapy in triple-negative breast cancer: Co-delivery of doxorubicin and berberine using nanoparticles to downregulate PD-L1 and eliminate cancer stem cells. Int J Pharm 670:125134. https:\/\/doi.org\/10.1016\/j.ijpharm.2024.125134","journal-title":"Int J Pharm"},{"issue":"3","key":"12187_CR40","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1080\/10799893.2021.1892132","volume":"42","author":"E Z.Yin","year":"2022","unstructured":"Z.Yin E, Chen X, Cai et al (2022) Baicalin Attenuates XRCC1-Mediated DNA Repair to Enhance the Sensitivity of Lung Cancer Cells to Cisplatin. J Recept Signal Transduct Res 42(3):215\u2013224. https:\/\/doi.org\/10.1080\/10799893.2021.1892132","journal-title":"J Recept Signal Transduct Res"},{"key":"12187_CR41","doi-asserted-by":"crossref","unstructured":"Pan X, Song Z, Cui Y, Qi M, Wu G, Wang M (2022) Enhancement of Sensitivity to Tamoxifen by Berberine in Breast Cancer Cells by Inhibiting ER-\u03b136 Expression, Iran J. Pharm Res 21","DOI":"10.5812\/ijpr-126919"},{"key":"12187_CR42","doi-asserted-by":"publisher","DOI":"10.1021\/acsanm.4c01269","author":"J Wu","year":"2024","unstructured":"Wu J, Lu Q, Zhao J et al (2024) Mixtures of Doxorubicin-Loaded Micelles and Berberine and Mifepristone Co-Loaded Liposomes Inhibit Breast Cancer Metastasis Based on Regulation of Tumor Microenvironments. ACS Appl Nano Mater. https:\/\/doi.org\/10.1021\/acsanm.4c01269","journal-title":"ACS Appl Nano Mater"},{"key":"12187_CR43","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1167\/iovs.63.10.6","volume":"6310","author":"J Diao","year":"2022","unstructured":"Diao J, Chen X, Mou P, Ma X, Wei R (2022) Potential therapeutic activity of berberine in thyroid-associated ophthalmopathy: inhibitory effects on tissue remodeling in orbital fibroblasts. Invest Ophthalmol Vis Sci 6310:6. https:\/\/doi.org\/10.1167\/iovs.63.10.6","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"12187_CR44","doi-asserted-by":"crossref","unstructured":"Du H, Gu J, Peng Q, Wang X, Liu L, Shu X, He Q, Tan Y, Hasnain MS (2021) Berberine Suppresses EMT in Liver and Gastric Carcinoma Cells through Combination with TGF\u03b2R Regulating TGF-\u03b2\/Smad Pathway. Oxidative Medicine and Cellular Longevity 2021, 1\u2009\u2013\u200921","DOI":"10.1155\/2021\/2337818"},{"key":"12187_CR45","doi-asserted-by":"publisher","first-page":"154798","DOI":"10.1016\/j.phymed.2023.154798","volume":"114","author":"MY Wang","year":"2023","unstructured":"Wang MY, Zhang SS, An MF, Xia YF, Fan MS, Sun ZR, Zhang LJ, Zhao YL, Sheng J, Wang XJ (2023) Neferine ameliorates nonalcoholic steatohepatitis through regulating AMPK pathway. Phytomedicine 114:154798. https:\/\/doi.org\/10.1016\/j.phymed.2023.154798","journal-title":"Phytomedicine"},{"key":"12187_CR46","unstructured":"Yang Xiyan J, Hongjun Z, Jianhua et al (2025) Experimental study on berberine inhibiting triple-negative breast cancer growth by downregulating VEGF expression [J\/OL]. Asia-Pacific Traditional Medicine, 1\u20137. https:\/\/link.cnki.net\/urlid\/42.1727.R.20250710.1026.008"},{"key":"12187_CR47","doi-asserted-by":"publisher","first-page":"903800","DOI":"10.3389\/fonc.2022.903800","volume":"12","author":"J Chen","year":"2022","unstructured":"Chen J, Wei Y, Yang W, Huang Q, Chen Y, Zeng K et al (2022) IL-6: the link between inflammation, immunity and breast cancer. Front Oncol 12:903800. https:\/\/doi.org\/10.3389\/fonc.2022.903800","journal-title":"Front Oncol"},{"key":"12187_CR48","doi-asserted-by":"publisher","first-page":"4523","DOI":"10.1016\/j.ejphar.2023.175586","volume":"949","author":"S GHALEHBANDI","year":"2023","unstructured":"Ghalehbandi S, Yuzugulen J, Pranjol M Z I et al (2023) The role of VEGF in cancer-induced angiogenesis and research progress of drugs targeting VEGF . Eur J Pharmacol 949:4523","journal-title":"Eur J Pharmacol"},{"key":"12187_CR49","doi-asserted-by":"publisher","first-page":"107753","DOI":"10.1016\/j.pharmthera.2020.107753","volume":"221","author":"Y Xiao","year":"2021","unstructured":"Xiao Y, Yu D (2021) Tumor microenvironment as a therapeutic target in cancer. Pharmacol Ther 221:107753","journal-title":"Pharmacol Ther"},{"issue":"9","key":"12187_CR50","first-page":"973","volume":"40","author":"J Zhao","year":"2024","unstructured":"Zhao J, u Y (2024) Clinical significance of PIK3CA mutation in breast cancer and its detection research progress. J Clin Experimental Pathol 40(9):973\u2013978","journal-title":"J Clin Experimental Pathol"},{"key":"12187_CR51","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/s13045-021-01053-x","volume":"14","author":"BG Kim","year":"2021","unstructured":"Kim BG, Malek E, Choi SH, Ignatz-Hoover JJ, Driscoll JJ (2021) Novel therapies emerging in oncology to target the TGF-\u03b2 pathway. J Hematol Oncol 14:55","journal-title":"J Hematol Oncol"},{"key":"12187_CR52","first-page":"261","volume":"36","author":"C Chunmiao","year":"2020","unstructured":"Chunmiao C, Guozhe Z, Pingping L, Huoyuefang L, Tingli (2020) Berberine inhibits TGF-\u03b21-induced epithelial-mesenchymal transition in human liver cancer HepG2 cells via TGF-\u03b2\/Smad pathway. Chin J Pharmacol 36:261\u2013267","journal-title":"Chin J Pharmacol"},{"key":"12187_CR53","doi-asserted-by":"publisher","first-page":"11679","DOI":"10.1002\/jcp.27835","volume":"234","author":"C Huang","year":"2019","unstructured":"Huang C, Tao L, Wang XL, Pang Z (2019) Berberine reversed the epithelialmesenchymal transition of normal colonic epithelial cells induced by SW480 cells through regulating the important components in the TGF-\u03b2 pathway. J Cell Physiol 234:11679\u201311691","journal-title":"J Cell Physiol"},{"key":"12187_CR54","doi-asserted-by":"publisher","first-page":"123898","DOI":"10.1016\/j.ijpharm.2024.123898","volume":"653","author":"J Sun","year":"2024","unstructured":"Sun J, Ye T, Chen X et al (2024) A self-assembly active nanomodulator based on berberine for photothermal immunotherapy of breast cancer via dual regulation of immune suppression. Int J Pharmaceut 653:123898. https:\/\/doi.org\/10.1016\/j.ijpharm.2024.123898","journal-title":"INT J PHARMACEUT"},{"key":"12187_CR55","doi-asserted-by":"publisher","first-page":"370","DOI":"10.2741\/4489","volume":"22","author":"AK Kozlowska","year":"2017","unstructured":"Kozlowska AK, Kaur K, Topchyan P et al (2017) Novel strategies to target cancer stem cells by NK cells; studies in humanized mice [J]. Front Biosci (Landmark Ed) 22:370\u2013384","journal-title":"Front Biosci (Landmark Ed)"},{"issue":"2","key":"12187_CR56","doi-asserted-by":"publisher","first-page":"104532","DOI":"10.1016\/j.cdnut.2024.104532","volume":"9","author":"N Ibrahim","year":"2025","unstructured":"Ibrahim N, Alsadi N, Yasavoli-Sharahi H et al (2025) Berberine Inhibits Breast Cancer Stem Cell Development and Decreases Inflammation: Involvement of miRNAs and IL-6. Curr Dev Nutr 9(2):104532. https:\/\/doi.org\/10.1016\/j.cdnut.2024.104532","journal-title":"Curr Dev Nutr"},{"issue":"2","key":"12187_CR57","doi-asserted-by":"publisher","first-page":"459","DOI":"10.3390\/ijms19020459","volume":"19","author":"S Ramassone","year":"2018","unstructured":"Ramassone S, Pagotto A, Veronese R, Visone (2018) Epigenetics and microRNAs in cancer. Int J Mol Sci 19(2):459. https:\/\/doi.org\/10.3390\/ijms19020459","journal-title":"Int J Mol Sci"},{"issue":"5","key":"12187_CR58","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.3892\/ijo.2017.3945","volume":"50","author":"Y Ding","year":"2017","unstructured":"Ding Y, Zhang C, Zhang J, Zhang N, Li T, Fang J, Zhang Y, Zuo F, Tao Z, Tang S, Zhu W, Chen H, Sun X (2017) miR-145 inhibits proliferation and migration of breast cancer cells by directly or indirectly regulating TGF-\u03b21 expression. Int J Oncol 50(5):1701\u20131710. https:\/\/doi.org\/10.3892\/ijo.2017.3945","journal-title":"Int J Oncol"},{"issue":"5","key":"12187_CR59","doi-asserted-by":"publisher","first-page":"4522","DOI":"10.3390\/ijms24054522","volume":"24","author":"CL Alves","year":"2023","unstructured":"Alves CL, Ditzel HJ (2023) Drugging the PI3K\/AKT\/mTOR pathway in ER+Breast Cancer. Int J Mol Sc 24(5):4522. https:\/\/doi.org\/10.3390\/ijms24054522","journal-title":"Int J Mol Sc"},{"key":"12187_CR60","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.1007\/s40265-020-01394-w","volume":"80","author":"SE Nunnery","year":"2020","unstructured":"Nunnery SE, Mayer IA (2020) Targeting the PI3K\/AKT\/mTOR pathway in Hormone-Positive breast Cancer. Drugs 80:1685\u20131697. https:\/\/doi.org\/10.1007\/s40265-020-01394-w","journal-title":"Drugs"},{"issue":"1","key":"12187_CR61","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1080\/13880209.2020.1865407","volume":"59","author":"G Li","year":"2021","unstructured":"Li G, Zhang C, Liang W, Zhang Y, Shen Y, Tian X (2021) Berberine Regulates the Notch1\/PTEN\/PI3K\/AKT\/mTOR Pathway and Acts Synergistically With 17-AAG and SAHA in SW480 Colon Cancer Cells. Pharm Biol 59(1):21\u201330. https:\/\/doi.org\/10.1080\/13880209.2020.1865407","journal-title":"Pharm Biol"},{"key":"12187_CR62","doi-asserted-by":"publisher","unstructured":"Montero JC, Espar\u00eds-Ogando A, Re-Louhau MF, Seoane S, Abad M, Calero R, Oca\u00f1a A, Pandiella A (2014) Active kinase profiling, genetic and pharmacological data define mTOR as an important common target in triple-negative breast cancer,Oncogene 33 (2 33) 148\u2013156. https:\/\/doi.org\/10.1038\/onc.2012.572","DOI":"10.1038\/onc.2012.572"},{"key":"12187_CR63","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1016\/j.biopha.2017.09.010","volume":"95","author":"L Li","year":"2017","unstructured":"Li L, Wang X, Sharvan R, Gao J, Qu S (2017) Berberine could inhibit thyroid carcinoma cells by inducing mitochondrial apoptosis, G0\/G1 cell cycle arrest and suppressing migration via PI3K-AKT and MAPK signaling pathways. Biomed Pharmacother 95:1225\u20131231. https:\/\/doi.org\/10.1016\/j.biopha.2017.09.010","journal-title":"Biomed Pharmacother"},{"key":"12187_CR64","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s13058-023-01620-9","volume":"25","author":"ZH Chen","year":"2023","unstructured":"Chen ZH, Tian Y, Zhou GL, Yue HR, Zhou XJ, Ma HY et al (2023) CMTM7 inhibits breast cancer progression by regulating Wnt\/\u03b2-catenin signaling. Breast Cancer Res 25:22","journal-title":"Breast Cancer Res"},{"key":"12187_CR65","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1093\/jpp\/rgac067","volume":"75","author":"SY Li","year":"2023","unstructured":"Li SY, Shi CJ, Fu WM, Zhang JF (2023) Berberine inhibits tumour growth in vivo and in vitro through suppressing the lincROR-Wnt\/\u03b2-catenin regulatory axis in colorectal cancer. J Pharm Pharmacol 75:129\u2013138","journal-title":"J Pharm Pharmacol"},{"key":"12187_CR66","doi-asserted-by":"publisher","first-page":"113217","DOI":"10.1016\/j.phytochem.2022.113217","volume":"200","author":"L Dian","year":"2022","unstructured":"Dian L, Xu Z, Sun Y, Li J, Lu H, Zheng M et al (2022) Berberine alkaloids inhibit the proliferation and metastasis of breast carcinoma cells involving Wnt\/\u03b2-catenin signaling and EMT. Phytochemistry 200:113217","journal-title":"Phytochemistry"},{"key":"12187_CR67","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1124\/molpharm.120.000029","volume":"99","author":"K Vishnoi","year":"2021","unstructured":"Vishnoi K, Ke R, Saini KS, Viswakarma N, Nair RS, das S et al (2021) Berberine represses \u03b2-catenin translation involving 4E-BPs in hepatocellular carcinoma cells. Mol Pharmacol 99:1\u201316","journal-title":"Mol Pharmacol"},{"key":"12187_CR68","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1038\/s41392-020-00450-x","volume":"6","author":"X Jiang","year":"2021","unstructured":"Jiang X, Liu B, Nie Z, Duan L, Xiong Q, Jin Z et al (2021) The role of m6A modification in the biological functions and diseases. Signal Transduct Target Ther 6:74","journal-title":"Signal Transduct Target Ther"},{"key":"12187_CR69","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1038\/s41580-019-0168-5","volume":"20","author":"S Zaccara","year":"2019","unstructured":"Zaccara S, Ries RJ, Jaffrey SR (2019) Reading, writing and erasing mRNA methylation. Nat Rev Mol Cell Biol 20:608\u2013624","journal-title":"Nat Rev Mol Cell Biol"},{"key":"12187_CR70","doi-asserted-by":"publisher","first-page":"e220110","DOI":"10.1530\/JME-22-0110","volume":"70","author":"BJ Petri","year":"2023","unstructured":"Petri BJ, Klinge CM (2023) m6A readers, writers, erasers, and the m6A epitranscriptome in breast cancer. J Mol Endocrinol 70:e220110","journal-title":"J Mol Endocrinol"},{"key":"12187_CR71","doi-asserted-by":"publisher","first-page":"e1427","DOI":"10.1002\/ctm2.1427","volume":"13","author":"X Zhang","year":"2023","unstructured":"Zhang X, Shi L, Sun HD, Wang ZW, Xu F, Wei JF et al (2023) IGF2BP3 mediates the mRNA degradation of NF1 to promote triple-negative breast cancer progression via an m6A-dependent manner. Clin Transl Med 13:e1427","journal-title":"Clin Transl Med"},{"key":"12187_CR72","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/s12943-021-01447-y","volume":"21","author":"W Wan","year":"2022","unstructured":"Wan W, Ao X, Chen Q, Yu Y, Ao L, Xing W et al (2022) METTL3\/IGF2BP3 axis inhibits tumor immune surveillance by upregulating N(6)-methyladenosine modification of PD-L1 mRNA in breast cancer. Mol Cancer 21:60","journal-title":"Mol Cancer"},{"key":"12187_CR73","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1111\/1759-7714.15321","volume":"15","author":"W Fu","year":"2024","unstructured":"Fu W, Liu L, Tong S (2024) Berberine inhibits the progression of breast cancer by regulating METTL3-mediated m6A modification of FGF7 mRNA. Thorac Cancer 15:1357\u20131368","journal-title":"Thorac Cancer"},{"key":"12187_CR74","first-page":"299","volume":"16","author":"J Hu","year":"2024","unstructured":"Hu J, Duan H, Zou J, Ding W, Wei Z, Peng Q et al (2024) METTL3-dependent N6-methyladenosine modification is involved in berberine-mediated neuroprotection in ischemic stroke by enhancing the stability of NEAT1 in astrocytes. Aging 16:299\u2013321","journal-title":"Aging"},{"key":"12187_CR75","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1615\/JEnvironPatholToxicolOncol.2021039718","volume":"41","author":"J Gong","year":"2022","unstructured":"Gong J, Wang C, Zhang F, Lan W (2022) Effects of Allocryptopine on the proliferation and epithelial-mesenchymal transition of oral squamous cell carcinoma through m6A mediated hedgehog signaling pathway. J Environ Pathol Toxicol Oncol 41:15\u201324","journal-title":"J Environ Pathol Toxicol Oncol"},{"key":"12187_CR76","doi-asserted-by":"publisher","first-page":"567","DOI":"10.3892\/or.2016.4785","volume":"36","author":"Y Zhao","year":"2016","unstructured":"Zhao Y, Jing Z, Li Y, Mao W (2016) Berberine in combination with cisplatin suppresses breast cancer cell growth through induction of DNA breaks and caspase-3-dependent apoptosis. Oncol Rep 36:567\u2013572","journal-title":"Oncol Rep"},{"issue":"7","key":"12187_CR77","doi-asserted-by":"publisher","first-page":"2341","DOI":"10.31557\/APJCP.2022.23.7.2341","volume":"23","author":"SNA Azzahra","year":"2022","unstructured":"Azzahra SNA, Hanif N, Hermawan A (2022) MDM2 is a Potential Target Gene of Glycyrrhizic Acid for Circumventing Breast Cancer Resistance to Tamoxifen: Integrative Bioinformatics Analysis. Asian Pac J Cancer Prev 23(7):2341\u20132350. https:\/\/doi.org\/10.31557\/APJCP.2022.23.7.2341","journal-title":"Asian Pac J Cancer Prev"},{"key":"12187_CR78","doi-asserted-by":"publisher","first-page":"606907","DOI":"10.3389\/fonc.2021.606907","volume":"11","author":"M Llaguno-Munive","year":"2021","unstructured":"Llaguno-Munive M, Vazquez-Lopez MI, Jurado R, GarciaLopez P (2021) Mifepristone Repurposing in Treatment of High-Grade Gliomas. Front Oncol 11:606907","journal-title":"Front Oncol"},{"issue":"3","key":"12187_CR79","doi-asserted-by":"publisher","first-page":"2291","DOI":"10.1007\/s11033-021-06255-7","volume":"48","author":"R Aida","year":"2021","unstructured":"Aida R, Hagiwara K, Okano K, Nakata K, Obata Y, Yamashita T (2021) miR-34a-5p might have an important role for inducing apoptosis bydown-regulation of SNAI1 in apigenin-treated lung cancer cells. Mol Biol Rep 48(3):2291\u20132297. https:\/\/doi.org\/10.1007\/s11033-021-06255-7","journal-title":"Mol Biol Rep"},{"issue":"4","key":"12187_CR80","doi-asserted-by":"publisher","first-page":"2025","DOI":"10.1002\/ptr.6945","volume":"35","author":"M Mohammadlou","year":"2021","unstructured":"Mohammadlou M, Abdollahi M, Hemati M, Baharlou R, Doulabi EM, Pashaei M et al (2021) Apoptotic effect of berberine via Bcl-2, ROR1, and mir\u201021 in patients with B\u2010CHRONIC lymphocytic leukemia. Phytother Res 35(4):2025\u20132033. https:\/\/doi.org\/10.1002\/ptr.6945","journal-title":"Phytother Res"},{"issue":"6","key":"12187_CR81","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1002\/biof.1131","volume":"39","author":"E Pierpaoli","year":"2013","unstructured":"Pierpaoli E, Arcamone AG, Buzzetti F, Lombardi P, Salvatore C, Provinciali M (2013) Antitumor effect of novel Berberine derivatives in breast cancer cells. BioFactors 39(6):672\u2013679. https:\/\/doi.org\/10.1002\/biof.1131","journal-title":"BioFactors"},{"issue":"10","key":"12187_CR82","doi-asserted-by":"publisher","first-page":"103346","DOI":"10.1016\/j.arabjc.2021.103346","volume":"14","author":"Q Cheng","year":"2021","unstructured":"Cheng Q, Li F, Yan X, He J, Zhang H, Wang C et al (2021) Phytochemical and pharmacological studies on the genus Arcangelisia: A mini review. Arab J Chem 14(10):103346. https:\/\/doi.org\/10.1016\/j.arabjc.2021.103346","journal-title":"Arab J Chem"},{"key":"12187_CR83","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1002\/ijc.23518","volume":"123","author":"F Bertucci","year":"2008","unstructured":"Bertucci F, Finetti P, Cervera N, Esterni B, Hermitte F, Viens P, Birnbaum D (2008) Int J Cancer 123:236\u2013240 [PubMed: 18398844]","journal-title":"Int J Cancer"},{"key":"12187_CR84","doi-asserted-by":"publisher","first-page":"29","DOI":"10.3816\/CBC.2009.n.005","volume":"9","author":"F Kassam","year":"2009","unstructured":"Kassam F, Enright K, Dent R, Dranitsaris G, Myers J, Flynn C, Fralick M, Kumar R, Clemons M (2009) Clin Breast Cancer 9:29\u201333 [PubMed: 19299237]","journal-title":"Clin Breast Cancer"},{"key":"12187_CR85","doi-asserted-by":"crossref","unstructured":"Zhang L, Fang C, Xu X, Li A, Cai Q, Long X (2015) BioMed Res. Int (2015)","DOI":"10.1155\/2015\/904756"},{"key":"12187_CR86","doi-asserted-by":"publisher","unstructured":"Alajroush DR, Anderson BF, Bruce JA et al (2024) Enhancement of antitumor effects of berberine chloride with a copper(II) complex against human triple negative breast cancer: In vitro studies. Results Chem 12. https:\/\/doi.org\/10.1016\/j.rechem.2024.101882","DOI":"10.1016\/j.rechem.2024.101882"},{"key":"12187_CR87","doi-asserted-by":"publisher","first-page":"829","DOI":"10.3390\/ijms24010829","volume":"241","author":"E Heh","year":"2023","unstructured":"Heh E, Allen J, Ramirez F, Lovasz D, Fernandez L, Hogg T, Riva H, Holland N, Chacon J (2023) Peptide drug conjugates and their role in cancer therapy. Int J Mol Sci 241:829. https:\/\/doi.org\/10.3390\/ijms24010829","journal-title":"Int J Mol Sci"},{"issue":"4","key":"12187_CR88","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1007\/s00280-019-03910-6","volume":"84","author":"AI Fraguas-Sanchez","year":"2019","unstructured":"Fraguas-Sanchez AI, Martin-Sabroso C, FernandezCarballido A, Torres-Suarez (2019) A. I. Current status of nanomedicine in the chemotherapy of breast cancer. Cancer Chemother Pharmacol 84(4):689\u2013706","journal-title":"Cancer Chemother Pharmacol"},{"key":"12187_CR89","doi-asserted-by":"publisher","first-page":"113909","DOI":"10.1016\/j.addr.2021.113909","volume":"178","author":"W Yu","year":"2021","unstructured":"Yu W, Hu C, Gao H (2021) Advances of nanomedicines in breast cancer metastasis treatment targeting different metastatic stages. Adv Drug Deliv Rev 178:113909","journal-title":"Adv Drug Deliv Rev"},{"key":"12187_CR90","doi-asserted-by":"publisher","first-page":"121584","DOI":"10.1016\/j.carbpol.2023.121584","volume":"326","author":"S Maiti","year":"2024","unstructured":"Maiti S, Maji B, Yadav H (2024) Progress on green crosslinking of polysaccharide hydrogels for drug delivery and tissue engineering applications. Carbohydr Polym 326:121584. https:\/\/doi.org\/10.1016\/j.carbpol.2023.121584","journal-title":"Carbohydr Polym"},{"key":"12187_CR91","doi-asserted-by":"publisher","first-page":"119999","DOI":"10.1016\/j.carbpol.2022.119999","volume":"291","author":"A Zak","year":"2022","unstructured":"Zak A, \u0141azarski \u02d9G, Wytrwal-Sarna M, Jamroz D, Gorniewicz \u00b4M, Fory\u00b4s \u00b4A, Trzebicka B, Kepczynski M (2022) Molecular insights into the self-assembly of hydrophobically modified chondroitin sulfate in aqueous media. Carbohydr Polym 291:119999. https:\/\/doi.org\/10.1016\/j.carbpol.2022.119999","journal-title":"Carbohydr Polym"},{"key":"12187_CR92","doi-asserted-by":"publisher","first-page":"800481","DOI":"10.3389\/fphar.2021.800481","volume":"12","author":"P Kesharwani","year":"2021","unstructured":"Kesharwani P, Chadar R, Sheikh A, Rizg WY, Safhi AY (2021) CD44-targeted Nanocarrier for Cancer therapy. Front Pharmacol 12:800481. https:\/\/doi.org\/10.3389\/fphar.2021.800481","journal-title":"Front Pharmacol"},{"key":"12187_CR93","doi-asserted-by":"publisher","unstructured":"Buiel J, Robert J, Mekhjian D et al (2025) Photothermal Therapy: From Encouraging Lab Results to Lackluster Clinical Translation Adv Ther. https:\/\/doi.org\/10.1002\/adtp.202400347","DOI":"10.1002\/adtp.202400347"},{"issue":"2","key":"12187_CR94","doi-asserted-by":"publisher","first-page":"e70199","DOI":"10.1002\/ardp.70199","volume":"359","author":"AY Kolchanova","year":"2026","unstructured":"Kolchanova AY, Lyamzaev KG, Valutsa N et al (2026) Berberine C9-Derivatives Selective Cytotoxicity Depends on Balance Between Mitochondrial Damage and DNA Intercalation. Arc Pharm 359(2):e70199. https:\/\/doi.org\/10.1002\/ardp.70199","journal-title":"ARCH PHARM"},{"key":"12187_CR95","doi-asserted-by":"publisher","unstructured":"\u00d6zalp Y, Alloush T, Serak\u0131nc\u0131 N, Challenges Pharmaceuticals-Base et al (2026) ; 19 (4): 613. https:\/\/doi.org\/10.3390\/ph19040613","DOI":"10.3390\/ph19040613"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-12187-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-026-12187-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-12187-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T22:14:21Z","timestamp":1782857661000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-026-12187-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,30]]},"references-count":95,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["12187"],"URL":"https:\/\/doi.org\/10.1007\/s11033-026-12187-x","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,30]]},"assertion":[{"value":"9 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1034"}}